The collaboration with Rudolf Fehrmann has led to a publication in Journal of Nuclear Medicine. We used functional genomic mRNA profiling to identify novel targets for theranostic approaches in pancreatic cancer.
The manuscript can be viewed here: https://www.ncbi.nlm.nih.gov/pubmed/29051346
Data driven prioritization and review of targets for molecular based theranostic approaches in pancreatic cancer. Koller M, Hartmans E, de Groot DJA, Zhao XJ, van Dam GM, Nagengast W, Fehrmann RSN. J Nucl Med. 2017 Oct 19. pii: jnumed.117.198440. doi: 10.2967/jnumed.117.198440. [Epub ahead of print. PMID: 29051346Leave a reply →